v3.26.3
Capital Stock Repurchase Plan Transactions
9 Months Ended
Sep. 30, 2026
Capital Stock Repurchase Plan Transactions [Abstract]  
Capital Stock Repurchase Plan Transactions

15.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

Three months ended September 30,

Nine months ended September 30,

2026

2025

2026

2025

Total cost of repurchased shares (in thousands)

$

66,031 

$

180,776 

$

353,552 

$

253,477 

Shares repurchased

125,000 

407,500 

835,000 

532,500 

Weighted average price per share

$

528.24 

$

443.62 

$

423.42 

$

476.02 

In February 2026, the Board of Directors authorized $300.0 million for additional stock repurchases under Chemed’s existing share repurchase program. We currently have $73.7 million of authorization remaining under this share repurchase plan.